Abstract
EVALUATION OF THE POTENTIAL ROLE OF EUGENOL IN INDUCED ARTHRITIS AND DIABETES MELLITUS IN RATS

*Hala I. Madkour

ABSTRACT

Background: Systemic inflammatory burden in rheumatoid arthritis (RA) has been shown to predispose to developing both insulin resistance and type 2 diabetes mellitus (DM). Polypharmacy with cumulative side effects are common problems met with in these medical situations of combined diseases. Aim of the work: the present study evaluates the potential role of eugenol as a natural product with anti-inflammatory and hypoglycemic activities in combating both DM and RA in experimental animals. Materials and methods: Twenty four male albino rats were used. Eight male rats were used as a normal control group received saline (group1). Arthritis was induced in 16 male albino rats by intradermal injection of 0.1 ml of Freund’s Complete Adjuvant (FCA) in the right hind paw then diabetes induced by alloxan (arthritic and diabetic animals). Animals were divided into 2 groups. Arthritic and diabetic control received sesame oil oral (group 2). Arthritic and diabetic animals treated with eugenol 100 mg/kg/day orally (group 3). Treatment was started with eugenol after diabetes induction for two weeks. Results: arthritic and diabetic control animals showed significant elevation in serum level of C-reactive protein (CRP), nitric oxide (NO), malondialdehyde (MDA) tumor necrosis factor-α (TNF-α), hyperglycemia and dyslipidemia compared to normal control group. Treatment with eugenol exhibited significant reduction in serum level of CRP, NO, MDA, TNF-α, blood glucose level, triglycerides, total cholesterol and LDL compared with arthritic diabetic control group. There was insignificant change in HDL serum level. Conclusion: These results suggested that dietary supplementation with eugenol could beneficially treat hyperglycemia and dyslipidemia. Also, eugenol ameliorates RA and could be useful as a beneficial supplement in treatment of RA and DM.

Keywords: Rheumatoid arthritis, diabetes mellitus, eugenol, inflammatory mediators.


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: MAY ISSUE PUBLISHED

    MAY 2022 Issue has been successfully launched on 1 May 2022.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT